Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Stock Information for Nano Dimension Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nano Dimension Ltd.

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination
Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics
Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?
Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin
Nano Dimension Announces Sale of MarkForged, Inc. to Stratasys
Murchinson Invites Fellow Nano Dimension Shareholders to an Investor Call to Discuss the Current State of the Company
Nano Dimension Issues Letter to Shareholders
Nano Dimension Announces Financial Results for the First Quarter 2026

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.